Oxopiperazine derivatives for the treatment of pain and epilepsy
US8629149B2 · kind B2 · utility
1Cited by
6References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 3, 2010 |
| Grant date | Jan 14, 2014 |
| Priority date | — |
| Expiry date | Sep 3, 2030 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P29/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds of formula (I) which are useful in ameliorating conditions characterized by unwanted sodium and/or calcium channel actrvrh, particularly Nav 1, 7, Nav 1, 8, or Cav 3, 2 channel activity are disclosed. More specifically, compounds for use in the treatment of conditions such as epilepsy, cancer, pain, migraine, Parkinson's disease, depression, schizophrenia, psychosis, and tinnitus are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.